nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A4—Temozolomide—malignant glioma	0.322	1	CbGbCtD
Alfentanil—ORM1—vertebral column—malignant glioma	0.0334	0.27	CbGeAlD
Alfentanil—OPRM1—telencephalic ventricle—malignant glioma	0.0283	0.23	CbGeAlD
Alfentanil—OPRM1—brainstem—malignant glioma	0.00767	0.0622	CbGeAlD
Alfentanil—OPRM1—telencephalon—malignant glioma	0.0068	0.0552	CbGeAlD
Alfentanil—Injection site pain—Carmustine—malignant glioma	0.00673	0.0546	CcSEcCtD
Alfentanil—OPRM1—midbrain—malignant glioma	0.00489	0.0396	CbGeAlD
Alfentanil—OPRM1—spinal cord—malignant glioma	0.00477	0.0386	CbGeAlD
Alfentanil—ORM1—spinal cord—malignant glioma	0.00465	0.0377	CbGeAlD
Alfentanil—ABCB1—blood vessel—malignant glioma	0.00404	0.0328	CbGeAlD
Alfentanil—OPRM1—central nervous system—malignant glioma	0.00387	0.0314	CbGeAlD
Alfentanil—ORM1—central nervous system—malignant glioma	0.00377	0.0306	CbGeAlD
Alfentanil—OPRM1—brain—malignant glioma	0.00307	0.0249	CbGeAlD
Alfentanil—Connective tissue disorder—Carmustine—malignant glioma	0.00271	0.022	CcSEcCtD
Alfentanil—Visual impairment—Carmustine—malignant glioma	0.00266	0.0216	CcSEcCtD
Alfentanil—ALB—brain—malignant glioma	0.00263	0.0213	CbGeAlD
Alfentanil—Connective tissue disorder—Temozolomide—malignant glioma	0.00262	0.0212	CcSEcCtD
Alfentanil—Eye disorder—Carmustine—malignant glioma	0.00258	0.0209	CcSEcCtD
Alfentanil—Visual impairment—Temozolomide—malignant glioma	0.00257	0.0208	CcSEcCtD
Alfentanil—Eye disorder—Temozolomide—malignant glioma	0.00249	0.0202	CcSEcCtD
Alfentanil—Cardiac disorder—Temozolomide—malignant glioma	0.00247	0.0201	CcSEcCtD
Alfentanil—Arrhythmia—Carmustine—malignant glioma	0.00246	0.02	CcSEcCtD
Alfentanil—Angiopathy—Temozolomide—malignant glioma	0.00242	0.0196	CcSEcCtD
Alfentanil—Mental disorder—Carmustine—malignant glioma	0.00242	0.0196	CcSEcCtD
Alfentanil—ABCB1—embryo—malignant glioma	0.00241	0.0196	CbGeAlD
Alfentanil—Immune system disorder—Temozolomide—malignant glioma	0.00241	0.0195	CcSEcCtD
Alfentanil—Mediastinal disorder—Temozolomide—malignant glioma	0.0024	0.0195	CcSEcCtD
Alfentanil—Erythema—Carmustine—malignant glioma	0.0024	0.0195	CcSEcCtD
Alfentanil—Chills—Temozolomide—malignant glioma	0.00239	0.0194	CcSEcCtD
Alfentanil—Mental disorder—Temozolomide—malignant glioma	0.00234	0.0189	CcSEcCtD
Alfentanil—Erythema—Temozolomide—malignant glioma	0.00232	0.0188	CcSEcCtD
Alfentanil—Vision blurred—Carmustine—malignant glioma	0.00226	0.0184	CcSEcCtD
Alfentanil—Agitation—Carmustine—malignant glioma	0.00221	0.0179	CcSEcCtD
Alfentanil—Vision blurred—Temozolomide—malignant glioma	0.00219	0.0177	CcSEcCtD
Alfentanil—ABCB1—retina—malignant glioma	0.00213	0.0173	CbGeAlD
Alfentanil—Agitation—Temozolomide—malignant glioma	0.00213	0.0173	CcSEcCtD
Alfentanil—Convulsion—Carmustine—malignant glioma	0.00208	0.0169	CcSEcCtD
Alfentanil—Hypertension—Carmustine—malignant glioma	0.00207	0.0168	CcSEcCtD
Alfentanil—Cough—Temozolomide—malignant glioma	0.00202	0.0164	CcSEcCtD
Alfentanil—Convulsion—Temozolomide—malignant glioma	0.00201	0.0163	CcSEcCtD
Alfentanil—Hypertension—Temozolomide—malignant glioma	0.002	0.0162	CcSEcCtD
Alfentanil—Confusional state—Carmustine—malignant glioma	0.00198	0.016	CcSEcCtD
Alfentanil—ABCB1—telencephalon—malignant glioma	0.00196	0.0159	CbGeAlD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00196	0.0159	CcSEcCtD
Alfentanil—Tachycardia—Carmustine—malignant glioma	0.00191	0.0155	CcSEcCtD
Alfentanil—Confusional state—Temozolomide—malignant glioma	0.00191	0.0155	CcSEcCtD
Alfentanil—Anaphylactic shock—Temozolomide—malignant glioma	0.00189	0.0154	CcSEcCtD
Alfentanil—Nervous system disorder—Temozolomide—malignant glioma	0.00186	0.0151	CcSEcCtD
Alfentanil—Skin disorder—Temozolomide—malignant glioma	0.00184	0.0149	CcSEcCtD
Alfentanil—Hypotension—Carmustine—malignant glioma	0.00183	0.0149	CcSEcCtD
Alfentanil—Hyperhidrosis—Temozolomide—malignant glioma	0.00183	0.0148	CcSEcCtD
Alfentanil—Somnolence—Carmustine—malignant glioma	0.00174	0.0141	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Carmustine—malignant glioma	0.00169	0.0137	CcSEcCtD
Alfentanil—Somnolence—Temozolomide—malignant glioma	0.00168	0.0137	CcSEcCtD
Alfentanil—Pain—Carmustine—malignant glioma	0.00168	0.0136	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00164	0.0133	CcSEcCtD
Alfentanil—Fatigue—Temozolomide—malignant glioma	0.00163	0.0132	CcSEcCtD
Alfentanil—Pain—Temozolomide—malignant glioma	0.00162	0.0131	CcSEcCtD
Alfentanil—Feeling abnormal—Carmustine—malignant glioma	0.00161	0.0131	CcSEcCtD
Alfentanil—CYP3A4—central nervous system—malignant glioma	0.00158	0.0128	CbGeAlD
Alfentanil—Feeling abnormal—Temozolomide—malignant glioma	0.00156	0.0127	CcSEcCtD
Alfentanil—Body temperature increased—Carmustine—malignant glioma	0.00155	0.0126	CcSEcCtD
Alfentanil—ABCB1—medulla oblongata—malignant glioma	0.00154	0.0125	CbGeAlD
Alfentanil—Urticaria—Temozolomide—malignant glioma	0.0015	0.0122	CcSEcCtD
Alfentanil—Body temperature increased—Temozolomide—malignant glioma	0.0015	0.0121	CcSEcCtD
Alfentanil—Hypersensitivity—Carmustine—malignant glioma	0.00144	0.0117	CcSEcCtD
Alfentanil—ABCB1—midbrain—malignant glioma	0.00141	0.0114	CbGeAlD
Alfentanil—Asthenia—Carmustine—malignant glioma	0.00141	0.0114	CcSEcCtD
Alfentanil—Hypersensitivity—Temozolomide—malignant glioma	0.0014	0.0113	CcSEcCtD
Alfentanil—ABCB1—spinal cord—malignant glioma	0.00137	0.0111	CbGeAlD
Alfentanil—Asthenia—Temozolomide—malignant glioma	0.00136	0.011	CcSEcCtD
Alfentanil—Pruritus—Temozolomide—malignant glioma	0.00134	0.0109	CcSEcCtD
Alfentanil—Dizziness—Carmustine—malignant glioma	0.0013	0.0105	CcSEcCtD
Alfentanil—Dizziness—Temozolomide—malignant glioma	0.00125	0.0102	CcSEcCtD
Alfentanil—Vomiting—Carmustine—malignant glioma	0.00125	0.0101	CcSEcCtD
Alfentanil—Rash—Carmustine—malignant glioma	0.00124	0.01	CcSEcCtD
Alfentanil—Dermatitis—Carmustine—malignant glioma	0.00123	0.01	CcSEcCtD
Alfentanil—Headache—Carmustine—malignant glioma	0.00123	0.00996	CcSEcCtD
Alfentanil—Vomiting—Temozolomide—malignant glioma	0.0012	0.00977	CcSEcCtD
Alfentanil—Rash—Temozolomide—malignant glioma	0.00119	0.00969	CcSEcCtD
Alfentanil—Dermatitis—Temozolomide—malignant glioma	0.00119	0.00968	CcSEcCtD
Alfentanil—Headache—Temozolomide—malignant glioma	0.00119	0.00962	CcSEcCtD
Alfentanil—Nausea—Carmustine—malignant glioma	0.00116	0.00944	CcSEcCtD
Alfentanil—Nausea—Temozolomide—malignant glioma	0.00112	0.00912	CcSEcCtD
Alfentanil—ABCB1—central nervous system—malignant glioma	0.00112	0.00904	CbGeAlD
Alfentanil—ABCB1—cerebellum—malignant glioma	0.00109	0.00884	CbGeAlD
Alfentanil—ABCB1—brain—malignant glioma	0.000885	0.00718	CbGeAlD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000314	0.000728	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HEY1—malignant glioma	0.00031	0.000719	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCR4—malignant glioma	0.00031	0.000719	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KNG1—malignant glioma	0.000303	0.000702	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BCAN—malignant glioma	0.000302	0.000701	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIST1H3B—malignant glioma	0.000301	0.000698	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000301	0.000698	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IFNA2—malignant glioma	0.000296	0.000688	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000295	0.000684	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CXCL8—malignant glioma	0.000288	0.000668	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MMP3—malignant glioma	0.000287	0.000667	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000286	0.000663	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000285	0.000661	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—IDH2—malignant glioma	0.000283	0.000656	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000282	0.000653	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ASMT—malignant glioma	0.000281	0.000653	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000281	0.000653	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SOD1—malignant glioma	0.000281	0.000652	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000281	0.000651	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000281	0.000651	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000278	0.000646	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000278	0.000644	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JAG2—malignant glioma	0.000275	0.000638	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000271	0.00063	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000266	0.000616	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BCAN—malignant glioma	0.000264	0.000614	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000258	0.000599	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PTK2—malignant glioma	0.000258	0.000599	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000258	0.000598	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000255	0.000593	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000252	0.000585	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000246	0.00057	CbGpPWpGaD
Alfentanil—ALB—Metabolism—IDH2—malignant glioma	0.000243	0.000565	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—IDH1—malignant glioma	0.000243	0.000564	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000241	0.00056	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000237	0.000549	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000235	0.000546	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—H3F3A—malignant glioma	0.000232	0.000539	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—F2—malignant glioma	0.000231	0.000536	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.00023	0.000535	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCR3—malignant glioma	0.00023	0.000534	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000229	0.000532	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2B6—malignant glioma	0.000229	0.000531	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—BCHE—malignant glioma	0.000224	0.000521	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NTRK2—malignant glioma	0.000224	0.00052	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—YWHAE—malignant glioma	0.000224	0.00052	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FLT1—malignant glioma	0.000223	0.000517	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DUSP6—malignant glioma	0.000222	0.000515	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000222	0.000515	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000221	0.000513	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JAG1—malignant glioma	0.000219	0.000509	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH3—malignant glioma	0.000218	0.000507	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000217	0.000504	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PDGFB—malignant glioma	0.000217	0.000503	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FBXW7—malignant glioma	0.000215	0.000498	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000214	0.000496	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—IDH2—malignant glioma	0.000213	0.000495	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BDKRB2—malignant glioma	0.000211	0.000489	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—F2—malignant glioma	0.00021	0.000486	CbGpPWpGaD
Alfentanil—ALB—Metabolism—IDH1—malignant glioma	0.000209	0.000486	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CAV1—malignant glioma	0.000205	0.000477	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—COX8A—malignant glioma	0.000204	0.000473	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SPHK1—malignant glioma	0.000202	0.00047	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT2—malignant glioma	0.000202	0.000469	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CG—malignant glioma	0.000201	0.000466	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2B6—malignant glioma	0.0002	0.000465	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2C18—malignant glioma	0.000198	0.00046	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PTPN11—malignant glioma	0.000197	0.000457	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000197	0.000456	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH2—malignant glioma	0.000196	0.000454	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—FN1—malignant glioma	0.000196	0.000454	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—F2—malignant glioma	0.000196	0.000454	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000194	0.000451	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000192	0.000446	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KNG1—malignant glioma	0.000192	0.000445	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CG—malignant glioma	0.000187	0.000434	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000187	0.000434	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000186	0.000432	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—EGF—malignant glioma	0.000185	0.000429	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PTPN11—malignant glioma	0.000184	0.000427	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT2—malignant glioma	0.000184	0.000426	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—IDH1—malignant glioma	0.000183	0.000425	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000183	0.000425	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NTRK1—malignant glioma	0.000183	0.000424	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000182	0.000422	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTP1—malignant glioma	0.000179	0.000415	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SPHK1—malignant glioma	0.000177	0.000412	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CD—malignant glioma	0.000176	0.000409	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000175	0.000405	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAT—malignant glioma	0.000174	0.000403	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000174	0.000403	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ASMT—malignant glioma	0.000173	0.000402	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT2—malignant glioma	0.000171	0.000397	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00017	0.000395	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP3—malignant glioma	0.00017	0.000394	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.00017	0.000394	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000169	0.000393	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN2B—malignant glioma	0.000168	0.00039	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000167	0.000388	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CD—malignant glioma	0.000165	0.000382	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000164	0.000382	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—NCOR1—malignant glioma	0.000164	0.000381	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTK2—malignant glioma	0.000163	0.000379	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BCAN—malignant glioma	0.000163	0.000378	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL8—malignant glioma	0.000163	0.000377	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—BCHE—malignant glioma	0.000162	0.000377	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000162	0.000375	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HES1—malignant glioma	0.000161	0.000372	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTT1—malignant glioma	0.00016	0.000372	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC5A5—malignant glioma	0.00016	0.000372	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NCOR1—malignant glioma	0.00016	0.00037	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—RAF1—malignant glioma	0.000157	0.000365	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—IL2—malignant glioma	0.000155	0.000361	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CB—malignant glioma	0.000154	0.000357	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFRA—malignant glioma	0.000153	0.000355	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS1—malignant glioma	0.00015	0.000349	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00015	0.000348	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SPP1—malignant glioma	0.000148	0.000344	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL8—malignant glioma	0.000148	0.000343	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAF1—malignant glioma	0.000147	0.000341	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CB—malignant glioma	0.000143	0.000333	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL2—malignant glioma	0.000141	0.000328	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TERT—malignant glioma	0.000141	0.000326	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTT1—malignant glioma	0.000141	0.000326	CbGpPWpGaD
Alfentanil—ALB—Metabolism—BCHE—malignant glioma	0.00014	0.000324	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000139	0.000322	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC5A5—malignant glioma	0.000138	0.00032	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFB—malignant glioma	0.000137	0.000319	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGFR1—malignant glioma	0.000137	0.000317	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000136	0.000317	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—malignant glioma	0.000134	0.000312	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CAV1—malignant glioma	0.000134	0.000311	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS1—malignant glioma	0.000132	0.000306	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IL2—malignant glioma	0.000132	0.000306	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—IDH2—malignant glioma	0.000131	0.000305	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000131	0.000303	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CAV1—malignant glioma	0.00013	0.000302	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000129	0.0003	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—malignant glioma	0.000129	0.0003	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—malignant glioma	0.000129	0.000299	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000127	0.000295	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAT—malignant glioma	0.000126	0.000292	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—F2—malignant glioma	0.000124	0.000287	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FN1—malignant glioma	0.000124	0.000287	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2B6—malignant glioma	0.000123	0.000287	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BCHE—malignant glioma	0.000122	0.000284	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BAD—malignant glioma	0.000122	0.000284	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—malignant glioma	0.000122	0.000283	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH1—malignant glioma	0.000121	0.000281	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC5A5—malignant glioma	0.000121	0.000281	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CD80—malignant glioma	0.000119	0.000275	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NCOR1—malignant glioma	0.000119	0.000275	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—malignant glioma	0.000118	0.000275	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APC—malignant glioma	0.000118	0.000275	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—malignant glioma	0.000118	0.000273	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGF—malignant glioma	0.000117	0.000272	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTPN11—malignant glioma	0.000116	0.00027	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—IDH1—malignant glioma	0.000113	0.000262	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000113	0.000262	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—malignant glioma	0.000112	0.00026	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000111	0.000259	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BRAF—malignant glioma	0.000111	0.000258	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—malignant glioma	0.000111	0.000258	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SPHK1—malignant glioma	0.000109	0.000254	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT2—malignant glioma	0.000108	0.000252	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAT—malignant glioma	0.000108	0.000251	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—malignant glioma	0.000108	0.000251	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CD—malignant glioma	0.000107	0.000249	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2C18—malignant glioma	0.000107	0.000248	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CD—malignant glioma	0.000104	0.000242	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000103	0.000239	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NCOR1—malignant glioma	0.000102	0.000237	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—malignant glioma	0.000102	0.000237	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF2—malignant glioma	9.97e-05	0.000231	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—malignant glioma	9.74e-05	0.000226	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CAV1—malignant glioma	9.67e-05	0.000224	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—malignant glioma	9.51e-05	0.000221	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAT—malignant glioma	9.48e-05	0.00022	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—malignant glioma	9.37e-05	0.000217	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CB—malignant glioma	9.34e-05	0.000217	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MDM2—malignant glioma	9.33e-05	0.000217	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RAF1—malignant glioma	9.3e-05	0.000216	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—malignant glioma	9.25e-05	0.000215	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB2—malignant glioma	9.2e-05	0.000214	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CB—malignant glioma	9.08e-05	0.000211	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NCOR1—malignant glioma	8.95e-05	0.000208	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—malignant glioma	8.81e-05	0.000204	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—malignant glioma	8.74e-05	0.000203	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL8—malignant glioma	8.73e-05	0.000202	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTT1—malignant glioma	8.66e-05	0.000201	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—malignant glioma	8.5e-05	0.000197	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—malignant glioma	8.46e-05	0.000196	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—malignant glioma	8.43e-05	0.000196	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—malignant glioma	8.35e-05	0.000194	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2—malignant glioma	8.34e-05	0.000194	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CAV1—malignant glioma	8.33e-05	0.000193	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS1—malignant glioma	8.11e-05	0.000188	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTEN—malignant glioma	8.07e-05	0.000187	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.96e-05	0.000185	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—malignant glioma	7.89e-05	0.000183	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTEN—malignant glioma	7.85e-05	0.000182	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CD—malignant glioma	7.74e-05	0.00018	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—malignant glioma	7.65e-05	0.000178	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—malignant glioma	7.59e-05	0.000176	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BCHE—malignant glioma	7.54e-05	0.000175	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.45e-05	0.000173	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—malignant glioma	7.32e-05	0.00017	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CAV1—malignant glioma	7.3e-05	0.000169	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—malignant glioma	7.14e-05	0.000166	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—malignant glioma	7.09e-05	0.000164	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—malignant glioma	7.02e-05	0.000163	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.75e-05	0.000157	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—malignant glioma	6.69e-05	0.000155	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CD—malignant glioma	6.67e-05	0.000155	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—malignant glioma	6.65e-05	0.000154	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—malignant glioma	6.52e-05	0.000151	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—malignant glioma	6.42e-05	0.000149	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—malignant glioma	6.38e-05	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—malignant glioma	6.02e-05	0.00014	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—malignant glioma	6e-05	0.000139	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CD—malignant glioma	5.84e-05	0.000136	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAT—malignant glioma	5.84e-05	0.000136	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTEN—malignant glioma	5.83e-05	0.000135	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CB—malignant glioma	5.81e-05	0.000135	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—malignant glioma	5.76e-05	0.000134	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.69e-05	0.000132	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—malignant glioma	5.53e-05	0.000128	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NCOR1—malignant glioma	5.52e-05	0.000128	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—malignant glioma	5.35e-05	0.000124	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CB—malignant glioma	5.09e-05	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—malignant glioma	5.05e-05	0.000117	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTEN—malignant glioma	5.02e-05	0.000117	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—malignant glioma	4.65e-05	0.000108	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—malignant glioma	4.52e-05	0.000105	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CAV1—malignant glioma	4.5e-05	0.000104	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTEN—malignant glioma	4.4e-05	0.000102	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—malignant glioma	4.12e-05	9.55e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.1e-05	9.51e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—malignant glioma	3.95e-05	9.17e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.6e-05	8.36e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—malignant glioma	3.54e-05	8.22e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—malignant glioma	3.36e-05	7.8e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.14e-05	7.28e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—malignant glioma	3.11e-05	7.22e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—malignant glioma	3.11e-05	7.21e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—malignant glioma	2.9e-05	6.72e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTEN—malignant glioma	2.71e-05	6.29e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—malignant glioma	2.54e-05	5.89e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.91e-05	4.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—malignant glioma	1.56e-05	3.63e-05	CbGpPWpGaD
